HIV Ag/Ab (4th generation)
Qualitative determination of antibodies to Human Immunodeficiency Virus Types 1 and 2 (HIV-1, HIV-2), HIV-1 Group Oand p24 Antigen
| Format | REF | Size | Remark | Sample |
|---|---|---|---|---|
| Antigen /Antibody test | 51215 | 96 tests | Recomb. antigens, monocl. antibodies | Serum, plasma |
WHAT IS phi ?
The prostate health index (phi) is a mathematical formula that provides a probability of prostate cancer (PCa) by combining three tests (prostate-specific antigen [PSA], free PSA, and p2PSA) into a single score. Calculated by using an algorithm in the Beckman Coulter Access instrument, the phi score can provide more accurate information about the meaning of an elevated PSA level and the probability of finding prostate cancer on a biopsy.
STI ELITe MGB® Panel is a triplex PCR assay designed to detect and differentiate Chlamydia trachomatis, including the Swedish variant, Neisseria gonorrhoeae and Mycoplasma genitalium DNAs. The assay is CE-IVD validated on urine samples and cervical swabs*, in combination with ELITe InGenius®, a fully automated sample-to-result solution.
Tumour markers are proteins found in the blood, tissue or urine that may be directly produced by a tumour or by other tissues in response to the presence of a tumour.
Prostate cancer is the second most common cause of cancer in men. If it is detected early enough, it has a 90% cure rate. Carcinoembryonic Antigen (CEA), a non-specific cancer antigen produced in response to malignant cells, is measured in addition to total and free Prostate Specific Antigen (PSA). Therefore, testing for CEA simultaneously with PSA provides a more accurate diagnosis of prostate cancer. Randox Tumour PSA Array enables the simultaneous determination of these antigens in a single sample.
The product of the Philadelphia translocation, the BCR/ABL oncogene P210 isoform, is typically found in chronic myelogenous leukemia, and in acute lymphoid and myeloid leukemia, causing the cells to divide uncontrollably and inducing severe outcomes among patients. Detection and quantification of P210 BCR-ABL fusion gene, by molecular methods, is crucial for patient management, to initiate the appropriate treatment, measure the response to therapy and predict relapse
Acute coronary syndrome (ACS) refers to a range of acute myocardial states, ranging from unstable angina pectoris to acute myocardial infarction (AMI) with or without ST-segment elevation. Diagnosis and risk stratification (from low risk to high risk) are closely linked in ACS.
Biochemical markers in serum are used as analytical tools for the diagnosis in conjunction with physical examination, clinical history, electrocardiogram and imaging investigations. The Randox Cardiac Array enables the simultaneous determination of four cardiac markers (including late and early markers) from a single sample thus increasing the test result output to facilitate early detection , diagnosis and therapeutic monitoring.
Rapid and reliable detection of N. gonorrhoeae
Your molecular genetic test system for the rapid detection of Neisseria gonorrhoeae directly from patient specimens
FluoroType® NG is based on an innovative fluorescence-based technology and allows for the detection of Neisseria gonorrhoeae directly from urethral or cervical swabs and urine.
The product of the Philadelphia translocation, the BCR/ABL oncogene P190 isoform, is commonly found in acute lymphoid leukemia, a rare disease that can be fatal within a matter of months if untreated. Detection and quantification of P190 BCR-ABL fusion gene, by molecular methods, is crucial for patient management, to initiate the appropriate treatment and measure response to therapy.
A specific marker of severe bacterial infection and sepsis
Fully adapted for emergency conditions, VIDAS®B.R.A.H.M.S. PCT™aids physicians in making rational clinical decisions and allows optimized patient management. Results are available in only 20 minutes.
Procalcitonin has been demonstrated to:
